Myocardial Regeneration via Progenitor Cell-Derived Exosomes
In the past 20 years, a variety of cell products has been evaluated in terms of their capacity to treat patients with acute myocardial infarction and chronic heart failure. Despite initial enthusiasm, therapeutic efficacy has overall been disappointing, and clinical application is costly and complex...
Saved in:
Main Authors: | Janita A. Maring, Christien M. Beez, Volkmar Falk, Martina Seifert, Christof Stamm |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2017/7849851 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neural progenitor cell-derived exosomes in ischemia/reperfusion injury in cardiomyoblasts
by: Oiva Arvola, et al.
Published: (2025-02-01) -
Harnessing the Angiogenic Potential of Stem Cell-Derived Exosomes for Vascular Regeneration
by: F. Alcayaga-Miranda, et al.
Published: (2016-01-01) -
Mesenchymal stem cells derived exosomes: a new era in cardiac regeneration
by: Hossein Rayat Pisheh, et al.
Published: (2025-01-01) -
Exosome-Derived Noncoding RNAs as a Promising Treatment of Bone Regeneration
by: Bei Yin, et al.
Published: (2021-01-01) -
The Novel Methods for Analysis of Exosomes Released from Endothelial Cells and Endothelial Progenitor Cells
by: Jinju Wang, et al.
Published: (2016-01-01)